N/A N=246 Contraceptive Counseling Following an Abortion
Post Abortion Care
Primary: Contraceptive Acceptability and Use of Contraceptives During the 6-month Follow-up — 121; 86 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=96 Contraception and Pregnancy in Diabetes Mellitus
Diabetes Mellitus, Type 1 · Contraception
Primary: Number of Women 'Prepared for Pregnancy\ — 3 participants
N/A N=1,008 Innovative Model of Patient-Centered ConTraception
Contraception · Unintended Pregnancy
Primary: Unintended Pregnancy — 46; 25 Participants
N/A N=168 Initiating Contraception After Emergency Contraception From Pharmacy
Contraceptive Use After Emergency Contraception
Primary: Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) — 5; 13; 22; 0 participants — p=<0.001
N/A N=253 Computerized Contraceptive Decision Aid
Contraception · Decision Making · Satisfaction
Primary: Decisional Conflict Scale Score — 15; 10; 0; 0 score on a scale
N/A N=207 RCT: Can a Single Counseling Phone Call Improve Contraception After an Abortion?
Contraception
Primary: Number of Participants Using an Effective Contraceptive Method 6 Weeks After Abortion — 55; 55 Participants
N/A N=138 Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II
Contraceptive Usage · Opioid Dependence
Primary: Percentage of Participants With Verified Prescription Contraceptive Use at the 6-month Assessment — 5; 14; 23 Participants — p=<.001
N/A N=321 A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
Contraception
Primary: Continuation Rates — 82; 78; 83 participants
N/A N=272 Contraceptive Awareness and Reproductive Education
Pregnancy · Sexually Transmitted Infections
Primary: Number of Participants With Continuous Use of Highly Effective Contraceptives Over 9 Months. — 39; 29 Participants — p=>.05
N/A N=135 Reducing Adolescent Pregnancy
Pregnancy in Adolescence · Counseling · Contraception Behavior
Primary: Intention to Initiate Contraception — 59 Participants
N/A N=13 Providing Adolescent Contraception in the Emergency Room
Contraception
Primary: Length of Stay — 287 minutes
N/A N=786 Patient-Centered Support for Contraceptive Decision-Making
Contraception · Contraceptive Behavior
Primary: Contraceptive Continuation — 201; 174; 154; 118 Participants — p=0.46
N/A N=20 Patient Centered Postpartum Contraception App
Contraceptive Usage
Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale
N/A N=100 The Impact of Contraception on Postpartum Weight Loss
Weight
Primary: Weight — 3.2; 6.8; 7.0 percent weight lost — p=<0.05
Phase 4 N=600 Premature Discontinuation of Contraceptive Implants
Contraception Behavior
Primary: Number of Participants With Implant Continuation — 219; 225 Participants
N/A N=14 Hormonal Contraception and Vaginal Health
Contraceptive Usage · Vaginal Epithelial Disruption
Primary: Thickness of the Vaginal Epithelium (in mm)With Means and Standard Deviations Reported. — 0.01; -0.005; -0.02; .007 mm
N/A N=455 Implementation and Examination of Contraception Care for Hospitalized Adolescents With Mental Health Disorders
Contraception
Primary: Interest BC4Teens Care — 231 Participants
N/A N=984 MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
Contraceptive Use · Unintended Pregnancy
Primary: Contraceptive Use — 93.43; 94.46; 94.10 percentage of surveys — p=1.0
Phase 4 N=894 Long-Acting Reversible Contraception
Contraception
Primary: Contraceptive Method Discontinuation — 300; 62; 142 Participants
Phase 3 N=1,565 Study of the Safety and Contraceptive Efficacy of C31G Compared to Conceptrol®
Pregnancy
Primary: The Cumulative Probability of Typical-use 6 Month (183 Days) Pregnancy. — 0.12; 0.12 6 month probability of pregnancy
N/A N=1,919 Evaluation of Participant Responses to Educational Counseling About Different Combined Hormonal Contraceptive Choices (P06557)
Contraception
Primary: Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling — 1207; 1199; 60; 131 Participants — p=0.705
Phase 3 N=72 Pericoital Oral Contraception With Levonorgestrel
Healthy
Primary: Efficacy: the Pearl Index (Number of Pregnancies Per 100 Woman-years) in the Primary Evaluable Population (18-35) — 22.4 pregnancies per 100 woman years
Phase 4 N=46 Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
Insulin Sensitivity · Cardiovascular Risk · Perimenopausal Disorder
Primary: Change From Baseline in Insulin Sensitivity — -1.91; -5.63 min ^ -1 / mIU / L
N/A N=57 Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
Pregnancy
Primary: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception — 9; 13 participants
Phase 4 N=36 Impact of Combined Hormonal Contraceptives on UPA
Contraception
Primary: Number of Participants With Follicle Rupture — 1; 9 Participants
Phase 4 N=59 Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
HIV · Contraception
Primary: Percent of HIV Target Immune Cells Within Female Genital Mucosa and Blood — 26.6; 22.8; 16.9; 22.4 percentage of HIV target immune cells
N/A N=298 Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion
Abortion
Primary: Number of Participants Who Use Patch After Abortion, by Study Arm — 36; 42 Participants
Phase 3 N=3,324 Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel
Contraception
Primary: 6-Month (183 Days) Cumulative Pregnancy Percentage — 10.0; 10.5 pregnancy percentage
N/A N=197 Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
Breast Feeding · Contraception
Primary: Number of Participants Who Continued to Breastfeed at 6 Months — 15; 14; 8; 9 participants
Phase 3 N=1,384 AMP002 Phase III Contraceptive Study
Contraception
Primary: Number of Subjects With Pregnancy Outcomes to Measure Contraceptive Efficacy — 100 Participants